Novel inverse planning optimization algorithm for robotic radiosurgery: First clinical implementation and dosimetric evaluation.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 21 05 2019
revised: 23 07 2019
accepted: 25 07 2019
entrez: 14 9 2019
pubmed: 14 9 2019
medline: 30 1 2020
Statut: ppublish

Résumé

A novel optimization algorithm (VOLO™) for robotic radiosurgery in the Precision™ treatment planning system was evaluated for different SRS/SBRT treatments and compared with the previous Sequential Optimization (SO) algorithm. Fifty cases of brain, spine, prostate and lung tumors previously optimized with SO, were re-planned with VOLO™ algorithm keeping the same prescription, collimator type and size, optimization shells, and blocking structures. The dosimetric comparison involved target coverage, conformity (CI), gradient (GI) and homogeneity indexes, specific indicators of dose to OARs and number of nodes, beams, MU and delivery time. For brain only, plans were IRIS- and MLC-based (10 each). The remaining 30 plans were all IRIS-based. VOLO™ optimization was significantly superior for target coverage for prostate and spine, CI for brain, and for brain and urethra dose sparing. SO gave significantly better results for GI for prostate. VOLO™ showed a significantly steeper dose fall-off for brain MLC-based, while for prostate and spine SO was superior. For IRIS-based plans, VOLO™ significantly reduced the nodes (36%), beams (14%), and MU (31%). This led to an average reduction of delivery time of 20% (from 8% for brain to 30% for prostate). For MLC-based plans, VOLO™ significantly increased the nodes and beams (42%) keeping the same number of MU. The averaged delivery time increased by 18%. With respect to SO, VOLO™ optimization algorithm provided better results in terms of delivery time for IRIS-based and of quality of dose distribution for MLC-based plans, respectively.

Identifiants

pubmed: 31515024
pii: S1120-1797(19)30173-5
doi: 10.1016/j.ejmp.2019.07.020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-237

Informations de copyright

Copyright © 2019 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Auteurs

Michele Zeverino (M)

Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Maud Marguet (M)

Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Cedric Zulliger (C)

Radiation-oncology Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

André Durham (A)

Radiation-oncology Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Raphael Jumeau (R)

Radiation-oncology Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Fernanda Herrera (F)

Radiation-oncology Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Luis Schiappacasse (L)

Radiation-oncology Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Jean Bourhis (J)

Radiation-oncology Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Francois O Bochud (FO)

Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Raphael Moeckli (R)

Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: raphael.moeckli@chuv.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH